Allogeneic CMV-specific T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic CMV-specific T cells, covering 2018-05-02 to 2018-05-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM) [Phase 1]